Phase I Study of Vorinostat With Gefitinib in BIM Deletion Polymorphism/Egfr Mutation Double‐positive Lung Cancer

Cancer Science - United States
doi 10.1111/cas.14260
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Association of BIM Deletion Polymorphism and BIM-γ RNA Expression in NSCLC With EGFR Mutation

Cancer Genomics and Proteomics
MedicineBiochemistryGeneticsMolecular BiologyCancer Research
2016English

Effects of Antacids on Clinical Efficacy of Gefitinib in Patients With EGFR Mutation-Positive Non-Small Cell Lung Cancer

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
2017English

Phase I/Ii Study of Gefitinib (Iressa®) and Vorinostat (IVORI) in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2015English

Phase II Study of Erlotinib Plus Tivantinib (ARQ 197) in Patients With Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small-Cell Lung Cancer Just After Progression on EGFR-TKI, Gefitinib or Erlotinib

ESMO Open
Cancer ResearchOncology
2016English

Vorinostat Enhances Gefitinib‑induced Cell Death Through Reactive Oxygen Species‑dependent Cleavage of HSP90 and Its Clients in Non‑small Cell Lung Cancer With the EGFR Mutation

Oncology Reports
MedicineCancer ResearchOncology
2018English

P1.01-109 Phase I Study of Apatinib Plus Gefitinib as First-Line Therapy in Patients With EGFR Mutant Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Gefitinib Induces Premature Senescence in Non-Small Cell Lung Cancer Cells With or Without EGFR Gene Mutation

Oncology Reports
MedicineCancer ResearchOncology
2007English

P3.01-75 RELAY+, an Exploratory Study of Gefitinib With Ramucirumab in Untreated Patients With EGFR Mutation-Positive Metastatic NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

The Profile of Lung Adenocarcinoma Patients With Positive EGFR Mutation

Green Medical Journal
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy